Drug Shortage Report for IRINOTECAN HYDROCHLORIDE INJECTION USP

Last updated on 2017-03-23 History
Report ID 3252
Drug Identification Number 02357585
Brand name IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION
Common or Proper name IRINOTECAN
Company Name ACCORD HEALTHCARE INC
Market Status MARKETED
Active Ingredient(s) IRINOTECAN HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5 ML VIAL OF 100 MG | FLACON DE 5 ML DE 100 MG
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2016-12-27
Actual start date 2016-12-27
Estimated end date 2017-03-22
Actual end date 2017-03-22
Shortage status Resolved
Updated date 2017-03-23
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-17 English Compare
v2 2017-03-17 English Compare
v3 2017-03-17 French Compare
v4 2017-03-23 English Compare
v5 2017-03-23 French Compare
v6 2017-04-06 French Compare

Showing 1 to 6 of 6